Holen Sie sich die Stockscreener-App
1.15
1.77%
0.02
Schlusskurs vom Vortag:
$1.13
Offen:
$1.22
24-Stunden-Volumen:
73,472
Relative Volume:
0.17
Marktkapitalisierung:
$164.38M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-1.7692
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
-22.30%
1M Leistung:
-14.18%
6M Leistung:
-33.14%
1J Leistung:
-41.62%
1-Tages-Spanne:
$1.14
$1.2253
1-Wochen-Bereich:
$1.13
$1.5109
52-Wochen-Spanne:
$1.11
$2.21
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Vergleichen Sie BDSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
1.15 | 164.38M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
561.01 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
240.62 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
146.35 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.59 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
428.02 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-26 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-13 | Eingeleitet | TD Cowen | Buy |
| 2024-05-03 | Eingeleitet | Lake Street | Buy |
| 2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Eingeleitet | BTIG Research | Buy |
| 2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
BDSX Stock Rises After Publication of Study Data for Nodify CDT Test - MSN
Biodesix, Inc. (NASDAQ:BDSX) Shares Bought by Barclays PLC - Defense World
Preliminary results show sales boost for Biodesix - BizWest
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) - GlobeNewswire
Biodesix Achieves Record 45% Revenue Growth to $71.3M as Lung Diagnostics Surges in 2024 - StockTitan
Geode Capital Management LLC Has $1.43 Million Stock Position in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - The Manila Times
Biodesix's Lung Cancer Blood Test Outperforms PET Scans in Major Clinical Study - StockTitan
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript - MSN
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Expands By 44.7% - MarketBeat
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Wilmington Savings Fund Society FSB Takes Position in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Best Project, Interior/Tenant: Biodesix Corporate Headquarters and Laboratory - Engineering News-Record
Insider Buys Additional US$234k In Biodesix Stock - Yahoo Finance
Biodesix director Jack Schuler buys $122,840 in stock By Investing.com - Investing.com Canada
Biodesix director Kennedy Lawrence T. Jr buys $40,561 in stock - Investing.com India
Biodesix director Kennedy Lawrence T. Jr buys $40,561 in stock By Investing.com - Investing.com Canada
Biodesix director Jack Schuler buys $122,840 in stock - Investing.com
Biodesix Inc director Jack Schuler buys $234,000 in shares - Investing.com India
Biodesix Inc director Jack Schuler buys $234,000 in shares By Investing.com - Investing.com UK
With A 26% Price Drop For Biodesix, Inc. (NASDAQ:BDSX) You'll Still Get What You Pay For - Simply Wall St
Biodesix Reports Strong Q3 2024 Growth in Diagnostics - MSN
Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Biodesix chief commercial officer sells shares worth $644 By Investing.com - Investing.com Australia
Biodesix chief commercial officer sells shares worth $644 - Investing.com India
Biodesix CEO Scott Hutton sells $5,219 in stock - Investing.com India
Biodesix CEO Scott Hutton sells $5,219 in stock By Investing.com - Investing.com Australia
Biodesix CFO Robin Harper Cowie sells $1,355 in stock By Investing.com - Investing.com Australia
Biodesix CFO Robin Harper Cowie sells $1,355 in stock - Investing.com
Biodesix chief accounting officer sells $283 in stock - Investing.com
Insider Buys Additional US$137k In Biodesix Stock - Simply Wall St
Biodesix chairman John Patience acquires $103,710 in stock - Investing.com India
Biodesix chairman John Patience acquires $103,710 in stock By Investing.com - Investing.com Australia
Biodesix director Jack Schuler buys $136k in stock - Investing.com
Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock - Investing.com
Biodesix director Matthew Strobeck acquires $55,915 in stock - Investing.com
Biodesix director Massarany buys $30,865 in common stock - Investing.com India
Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock By Investing.com - Investing.com Nigeria
Earnings call: Biodesix sees strong growth in Q3 with $18.2M revenue - Investing.com India
Brokerages Set Biodesix, Inc. (NASDAQ:BDSX) PT at $3.06 - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Biodesix (NASDAQ:BDSX) Releases Quarterly Earnings Results, Meets Expectations - MarketBeat
Biodesix reports Q3 EPS (7c), consensus (7c) - MSN
Biodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):